Chemical compounds formed at the time of production of active pharmaceutical ingredients (API) are generally known as pharmaceutical intermediates. These are the by-products generated during the API production, which have wide usage in the manufacture of bulk drugs including antibiotics, steroids, and vitamins. Also, pharmaceutical intermediates have wide applications in pharmaceutical companies for research and development purposes. The pharmaceutical industry is continuously witnessing growth from the last decade, which is majorly inducing growth of the pharmaceutical intermediates market.
The prevalence of chronic, neurological, and cardiovascular diseases (CVDs) is increasing globally and especially in the developing and underdeveloped countries. A report from the World Health Organisation (WHO) suggests that CVDs are the number one cause of deaths globally. Among the overall deaths in low- to middle- income countries are caused by CVDs and majorly due to heart attack and stroke. These factors are creating a need for improved and novel drugs, which is contributing to an increase in investment for research and development in the biopharma and pharma industries. Such activities are boosting demand for pharmaceutical intermediates and are driving growth of the market.
Additionally, the market is witnessing growth owing to increasing applications of pharmaceutical intermediates for antibiotics and therapeutics. This is one of the prominent trends observed in the market from the last few years. However, the market dynamics are having adverse impacts due to the presence of stringent regulations for the manufacturing drugs and especially APIs. Nonetheless, the factors such as growing demand for generic drugs, usage of steroids for different diseases, and improved technology for quality control systems are offering several opportunities for growth of the global pharmaceutical intermediates market.
The pharmaceutical intermediates market is segmented based on application, product type, distribution channel, and region. Of these, by product type, the market is segmented into GMP and non-GMP. By application, the market is segmented into antipyretic analgesics, antibiotics, vitamins, and others. By distribution channel, the market is divided into direct sales and distributors.
Based on the region, the pharmaceutical intermediates market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, North America is estimated to hold a substantial share in the revenue of the overall market and remain same during the forecast period tailed by Europe. The growth in both regions is primarily attributed to the presence of improved infrastructure and supportive government norms for research and development. However, Asia Pacific is estimated to be the fastest-growing region owing to the presence of a large population and robust unmet medicinal needs. In addition, the region is witnessing growth owing to increasing government investment in the pharmaceutical industry as well as for improving healthcare infrastructure.
The key players operating in the pharmaceutical intermediates market include ZCL Chemical Ltd., Aceto Corporation, A.R. Life Sciences Private Limited, Lianhetech, Vertellus Holdings LLC, Dishman Group, Codexis, Midas Pharma GmbH, Chemcon Specialty Chemical Pvt. Ltd., Easter Chemical Corporation, Cycle Pharma Chem, Dextra Laboratories Limited, Sanofi Winthrop Industries, and BASF SE.